CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection
- PMID: 16316401
- DOI: 10.1111/j.1439-0450.2005.00860.x
CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection
Abstract
To date cellular immune responses against parvovirus B19 (B19) have not been studied extensively. The aim of this study was to examine the T-cell response against the VP1-unique region as the immunodominant part of the viral structural protein VP1 in individuals with different courses of B19 infection. Therefore, a group of 13 parvovirus-positive probands was separated into subgroups characterized for recent or acute, past or persistent infection by means of the presence of specific immunoglobulin (Ig)M and IgG isotypes and of viral DNA in blood and tissue. Transiently transfected B-cells expressing VP1-unique region were used in ELISpot assays to investigate T-cell responses directed against the VP1-unique region in peripheral blood mononuclear cells (PBMC) of individual donors. Significant numbers of interferon-gamma (IFN-gamma) secreting lymphocytes were detectable in PBMC of all individuals with recent, acute or persistent B19 infection, but not in PBMC of donors with past B19 infection and seronegative individuals. A more detailed analysis of IFN-gamma producing cells by intracellular cytokine staining by flow cytometry revealed, that CD4(+) T cells but not CD8(+) cytotoxic lymphocytes (CTL) were the major subpopulation of IFN-gamma producing cells. These data strongly suggest the need of virus protein production for the maintenance of VP1-unique region-specific CD4(+) T-helper cell responses in B19-infected individuals.
Similar articles
-
T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.Vaccine. 2004 Sep 9;22(27-28):3809-15. doi: 10.1016/j.vaccine.2003.06.003. Vaccine. 2004. PMID: 15315862
-
Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis.J Intern Med. 2009 Sep;266(3):296-301. doi: 10.1111/j.1365-2796.2009.02117.x. Epub 2009 Apr 23. J Intern Med. 2009. PMID: 19549095
-
B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1.J Infect Dis. 2004 May 15;189(10):1873-80. doi: 10.1086/382963. Epub 2004 Apr 26. J Infect Dis. 2004. PMID: 15122524
-
Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.Clin Infect Dis. 2000 Jul;31(1):65-9. doi: 10.1086/313929. Epub 2000 Jul 14. Clin Infect Dis. 2000. PMID: 10913398 Review.
-
Antibody responses in parvovirus B19 infected patients.Pathol Biol (Paris). 2002 Jun;50(5):326-31. doi: 10.1016/s0369-8114(02)00302-4. Pathol Biol (Paris). 2002. PMID: 12116851 Review.
Cited by
-
CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults.J Infect Dis. 2008 Dec 1;198(11):1677-84. doi: 10.1086/592985. J Infect Dis. 2008. PMID: 18831690 Free PMC article.
-
Clinical and epidemiological aspects of human bocavirus infection.J Clin Virol. 2008 Dec;43(4):391-5. doi: 10.1016/j.jcv.2008.08.009. Epub 2008 Sep 26. J Clin Virol. 2008. PMID: 18823816 Free PMC article. Review.
-
Urea-mediated cross-presentation of soluble Epstein-Barr virus BZLF1 protein.PLoS Pathog. 2008 Nov;4(11):e1000198. doi: 10.1371/journal.ppat.1000198. Epub 2008 Nov 7. PLoS Pathog. 2008. PMID: 18989461 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous